Results 1 to 10 of about 1,072 (115)

Вплив комплексної терапії на якість життя у пацієнтів з артеріальною гіпертензією на фоні подагри

Journal of V. N. Karazin Kharkiv National University: Series Medicine, 2023
Анотація. Подагра залишається найпоширенішим типом запального артриту у всьому світі. У структурі коморбідних захворювань при подагрі переважає артеріальна гіпертензія.
Ганна Кузьміна, Ольга Лазаренко   +1 more
doaj   +1 more source

Vliyanie kompensatsii uglevodnogo obmenai terapii atorvastatinom na lipidnyy obmen i uroven' S-reaktivnogo belka u patsientov s sakharnym diabetom 2 tipa

Сахарный диабет, 2007
Цель. Изучение влияния компенсации углеводного обмена и терапии аторвастатином на показатели липидного спектра и атеросклеротическое воспаление у пациентов с СД 2 типа. Материалы и методы. В исследование были включены 26 пациентов с СД 2 типа. Критериями
Irina Vladimirovna Glinkina, Aleksey Vadimovich Zilov, Galina Afanas'evna Mel'nichenko, A P Roytman, A V Il'in   +4 more
doaj   +1 more source

THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION

Рациональная фармакотерапия в кардиологии, 2015
Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy on the prognosis in patients with ischemic heart disease (IHD) are presented.
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov   +2 more
doaj   +1 more source

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

Рациональная фармакотерапия в кардиологии, 2015
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
N. G. Gogolashvili
doaj   +1 more source

The effectiveness of atorvastatin in the prevention of stroke

Медицинский совет, 2015
Summary. The article examined the relationship between the risk of stroke and various profiles of lipid metabolism. The findings show that only statins, unlike many other lipid-lowering drugs, significantly reduce the risk of both primary and recurrent ...
O. D. Ostroumova, I. I. Kopchenov, Т. F. Guseva, O. V. Bondarets, G. N. Schukina   +4 more
doaj   +1 more source

STATINS IN PREVENTION OF ISCHEMIC STROKE

Рациональная фармакотерапия в кардиологии, 2015
The evidence base of statin therapy in primary and secondary prevention of ischemic stroke is surveyed. Results of classical trails with statins in ischemic stroke prevention as well as results of meta-analyses are discussed.
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk   +6 more
doaj   +1 more source

EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE

Рациональная фармакотерапия в кардиологии, 2015
Aim. To evaluate dynamics of endothelial vasoregulatory function in type 2 diabetic patients after 6 months of combined treatment with atorvastastin 20 mg/day depending on the disease duration and target lipid levels achievement.Material and methods. The
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh   +2 more
doaj   +1 more source

PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE

Рациональная фармакотерапия в кардиологии, 2015
Aim: to study cerebral blood flow and cholesterol metabolism in menopausal women with arterial hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations in these patients during 6-month antihypertensive and
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova   +3 more
doaj   +1 more source

Diagnosis and treatment of nonalcoholic fatty liver disease in patients with metabolic syndrome: potential of cardiac and antidiabetic medications

Медицинский совет, 2014
According to recent guidelines of AASLD, AGA and ACG, NAFLD is a liver disease accompanied by the accumulation of fatty acid content greater than 5% of hepatocytes weight, absence of substantial alcohol consumption (20 g per day for men, 10 g per day for
S. V. Nedogoda, T. N. Sanina, T. A. Chalyabi, I. N. Barykina, V. V. Tsoma, E. V. Chumachek, A. S. Salasyuk, V. Y. Khripaeva, V. O. Smirnova   +8 more
doaj   +1 more source

Aggressive lipid-lowering therapy before and after revascularization in patients with stable coronary artery disease

Медицинский совет, 2013
The review presents data on the effectiveness of lipid profile correction with maximum doses of statins, primarily atorvastatin, and lipoprotein apheresis.
R. N. Adzhiev, M. S. Safarova, M. V. Yezhov, Y. G. Matchin   +3 more
doaj   +1 more source